# GenIbet Biopharmaceuticals, S.A. – FDA Inspection, Jan 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/genibet-biopharmaceuticals-sa/a4db74d3-9f69-438f-9622-286f17aa8e56
Source feed: FDA_Inspections

> FDA inspection 1201486 of GenIbet Biopharmaceuticals, S.A., January 31, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201486
- Company Name: GenIbet Biopharmaceuticals, S.A.
- Inspection Date: 2023-01-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1259407 - 2025-01-21](https://www.keypedia.com/records/fda_inspections/genibet-biopharmaceuticals-sa/4e6121f5-c31c-4c26-bf2d-b6dd39f1a1ea)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kathleen-r-jones/3760ffcd-ce90-4b7c-b0a6-726edc8264d8)
- [Issuing Officer](https://www.keypedia.com/people/miriam-m-ngundi/3999979f-7a00-4d34-8aed-e4426351c99f)
- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/genibet-biopharmaceuticals-sa/0caa1843-f97a-4138-b02a-16af961df290

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
